A potential diagnostic biomarker for schizophrenia based on local functional connectivity using dynamic regional
Lizhao Du1, Hongna Huang2, Zhengping Pu2
1Shanghai Med-X Engineering Research Center, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
Schizophrenia Research
|March 22, 2025
Summary
Dynamic regional phase synchrony (DRePS) shows potential as a neuroimaging biomarker for schizophrenia (SZ). This method helps differentiate SZ from healthy controls and bipolar disorder (BD) patients.
Area of Science:
- Neuroimaging
- Psychiatry
- Computational Neuroscience
Background:
- Schizophrenia (SZ) diagnosis faces challenges due to symptomatic overlap with other mental disorders like bipolar disorder (BD).
- Objective neuroimaging markers are needed for accurate SZ diagnosis.
- Current diagnostic criteria for SZ can lead to inaccuracies.
Purpose of the Study:
- To investigate dynamic regional phase synchrony (DRePS) as a potential neuroimaging biomarker for SZ.
- To differentiate SZ from healthy controls (HC) and BD using DRePS.
- To assess the correlation of DRePS with clinical symptoms in SZ.
Main Methods:
- Functional magnetic resonance imaging (fMRI) and T1 data were collected from 931 participants (300 SZ, 145 BD, 486 HC).
- Dynamic regional phase synchrony (DRePS) of BOLD signals was analyzed.
- Support vector machine (SVM) models were trained and tested for classification tasks.
Main Results:
- SZ patients exhibited significantly reduced DRePS compared to HC.
- Significant differences in DRePS were observed between SZ and BD patients.
- DRePS showed a significant correlation with clinical symptom scores (PANSS) in SZ.
- SVM models achieved high accuracy in classifying SZ from HC (up to 85%) and SZ from BD (approx. 72%).
Conclusions:
- DRePS of BOLD signals is a promising neuroimaging biomarker for differentiating SZ from both HC and BD.
- DRePS is correlated with clinical symptoms, suggesting its prognostic value.
- This finding could improve diagnostic accuracy and clinical management of SZ.


